Health Trials

Zanzalintinib

1

Review clinical trials related to Zanzalintinib. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma

To learn if zanzalintinib and pembrolizumab can help to control select subtypes of advanced/metastatic soft-tissue sarcoma (UPS, MFS, HGPS, and HGUS

Participants needed: 20
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Apr 17, 2026Locations: 1
Eligibility criteria

Participants must have histologically or cytologically confirmed undifferentiate... [+16]

Prior treatment with immune checkpoint inhibitors (ICIs) [+46]

Read more